BIOCAN NOVEL DHPPI-L4R
MANUFACTURER: Bioveta
PRODUCT CATEGORY: Vaccines
COMPOSITION:
Lyophilisate
Canine Distemper virus, strain CDV Bio 11/A - min. 103.1 TCID50*, max. 105.1 TCID50*
Canine Adenovirus Type 2, strain CAV-2 Bio 13 - min. 103.6 TCID50**, max. 105.3 TCID50*
Canine Parvovirus Type 2b, strain CPV-2b Bio 12/B - min. 104.3 TCID50*, mix. 106.6 TCID50*
Canine Parainfluenza Type 2virus, strain CPiV-2 Bio 15 - min. 103.1 TCID50*, max. 105.1 TCID50*
Diluent (suspension of inactivated vaccine against leptospirosis and rabies)
Leptospira icterohaemorrhagiae, strain MSLB 1089 GMT** ≥ 1:51 ALR***
Leptospira canicola, strain MSLB 1090 GMT** ≥ 1:51 ALR***
Leptospira grippotyphosa, strain MSLB 1091 GMT** ≥ 1:40 ALR***
Leptospira bratislava, strain MSLB 1088 GMT** ≥ 1:51 ALR***
Inactivated rabies virus, strain SAD Vnukovo-32 > 2.0 IU****
Adjuvant: aluminium hydroxide Al (OH)3) 1.8-2.2 mg
* Tissue culture infectious dose – 50%
** Geometric mean titre
*** Antibody micro agglutination-lytic reaction
**** International Units;
TARGET SPECIES ANIMAL: Dogs
INDICATIONS WITH SPECIFICATION FOR THE TARGET ANIMAL SPECIES:
Active immunization of dogs from 8–9 weeks of age:
· to prevent mortality and clinical signs caused by canine distemper virus
· to prevent mortality and clinical signs caused by canine adenovirus type 1
· to prevent clinical signs and reduce viral excretion caused by canine adenovirus type 2, to prevent clinical signs, leukopenia and viral excretion caused by canine parvovirus
· to prevent clinical signs (nasal and ocular discharge) and reduce viral excretion caused by canine parainfluenza virus, to prevent clinical signs, infection and urinary excretion caused by L. interrogans serogroup Australis serovar Bratislava
· to prevent clinical signs and urinary excretion and reduce infection caused by L. interrogans serogroup Canicola serovar Canicola and L. interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae
· to prevent clinical signs and reduce infection and urinary excretion caused by L. kirschneri serogroup Grippotyphosa serovar Grippotyphosa
· to prevent mortality, clinical signs and infection caused by rabies virus
PACKAGING: 10x1dose, 25x1dose
